These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 12572624

  • 21. Management of hyperlipidemia: new LDL-C targets for persons at high-risk for cardiovascular events.
    Balbisi EA.
    Med Sci Monit; 2006 Feb; 12(2):RA34-9. PubMed ID: 16449961
    [Abstract] [Full Text] [Related]

  • 22. Optimal management of cholesterol levels and the prevention of coronary heart disease in women.
    Mosca LJ.
    Am Fam Physician; 2002 Jan 15; 65(2):217-26. PubMed ID: 11820486
    [Abstract] [Full Text] [Related]

  • 23. LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD.
    McKenney J, Ballantyne CM, Feldman TA, Brady WE, Shah A, Davies MJ, Palmisano J, Mitchel YB.
    MedGenMed; 2005 Jul 14; 7(3):3. PubMed ID: 16369229
    [Abstract] [Full Text] [Related]

  • 24. Coadministration of multidrug therapy to achieve lipid goals.
    Denke MA.
    J Am Osteopath Assoc; 2004 Sep 14; 104(9 Suppl 7):S17-22. PubMed ID: 15467020
    [Abstract] [Full Text] [Related]

  • 25. Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals.
    Feldman T, Koren M, Insull W, McKenney J, Schrott H, Lewin A, Shah S, Sidisin M, Cho M, Kush D, Mitchel Y.
    Am J Cardiol; 2004 Jun 15; 93(12):1481-6. PubMed ID: 15194017
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Aggressive lipid-lowering therapy: a clinical imperative.
    Pedersen TR.
    Eur Heart J; 1998 Oct 15; 19 Suppl M():M15-21. PubMed ID: 9821012
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
    Keevil JG, Cullen MW, Gangnon R, McBride PE, Stein JH.
    Circulation; 2007 Mar 20; 115(11):1363-70. PubMed ID: 17353444
    [Abstract] [Full Text] [Related]

  • 35. Update on lipid-lowering therapy and LDL-cholesterol targets.
    Wiviott SD, Cannon CP.
    Nat Clin Pract Cardiovasc Med; 2006 Aug 20; 3(8):424-36. PubMed ID: 16874355
    [Abstract] [Full Text] [Related]

  • 36. Differences between clinical trial efficacy and real-world effectiveness.
    Davidson MH.
    Am J Manag Care; 2006 Nov 20; 12(15 Suppl):S405-11. PubMed ID: 17112328
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
    Santos RD, Waters DD, Tarasenko L, Messig M, Jukema JW, Ferrières J, Verdejo J, Chiang CW, L-TAP 2 Investigators.
    Am Heart J; 2009 Nov 20; 158(5):860-6. PubMed ID: 19853709
    [Abstract] [Full Text] [Related]

  • 39. Past, present, and future standards for management of dyslipidemia.
    LaRosa JC, Gotto AM.
    Am J Med; 2004 Mar 22; 116 Suppl 6A():3S-8S. PubMed ID: 15050186
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.